About this trial
To assess the impact of preoperative anemia on postoperative outcomes in patients undergoing liver resection
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All genders, age 20 to 75 years old who undergoing elective liver resection
American Society of Anesthesiologists (ASA) physical status classification of I-III
Disqualifiers
Living donor liver resection
Unresectable tumor
Cardiac arrest during operation
Trial population
Patients who underwent elective liver resection in setting hospital during January, 2006 to December, 2024
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Postoperative 30-day morbidity rate
• To determine whether preoperative anemia is associated with increased risk of postoperative 30-day morbidity in patients undergoing liver resection.
Secondary outcomes
Allogenic blood transfusion, comprehensive complication index, postoperative outcomes, and mortality rate
* To determine the incidence of preoperative anemia in liver resection patients. * To determine the incidence of postoperative 30-day morbidities rate * To evaluated the postoperative 30-day morbidities rate, classified using: * Clavien Dindo classification * Comprehensive complication index (CCI) * To determine postoperative major complication, defined as Clavien-Dindo classification grade III or higher or CCI \> 40 * To assess the length of hospital stay * To assess the length of ICU stay and ventilator day * To evaluate postoperative 30-day mortality
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: